logo
  1. Home
  2. Stocks
  3. Bliss GVS Pharma

Bliss GVS Pharma Share Price

Small Cap | Pharmaceuticals and health care | NSE: BLISSGVS | BSE: 506197

₹114.29 image-2.13 (-1.83 %)

Last Updated: 13 Mar 2025 03:59 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 117.10

High (₹) 118.62

Low (₹) 113.25

Prev. Close (₹) 116.42

Volume 2,55,586

VWAP (₹) 126.48

ROCE (%) 14.51

Industry P/E 43.95

TTM P/E 20.19

P/B Ratio 1.19

Market Cap (₹) Cr.1,204.28

Dividend Yield (%)0.44

EPS (₹) 7.11

ROE7.42%

Sales Growth (%) 2.48

Profit Growth (%)6.31

Day Range

118.62118.62

L
H

52 Week Range

92.25184.95

L
H

Historical Returns

Returns (6M)

-13.01 %

Returns (1Y)

4.61 %

Returns (3Y)

55.71 %

Returns (5Y)

11.45 %

Returns (6M)

-13.01 %

Returns (1Y)

4.61 %

Returns (3Y)

55.71 %

Returns (5Y)

11.45 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with (5.80%) TTM EPS Growth
  • Company with Low Debt
  • Book value per share improving over the last 2 years
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Company with 5.80% positive TTM EPS growth
  • Increasing Annual Revenue for Past 2 Years
  • Growth in Net Profit Margin (QoQ)
  • Growth in Annual Net Profit with increasing Profit Margin (YoY)

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bearish
Bullish

RSI 40.77

MFI 43.53

ATR 8.65

Commodity Channel Index -128.29

ROC125 -1.20

ROC21 -20.41

Williams %R -91.63

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current129.31134.13137.71125.73120.91117.33112.51
Week Ago145.29149.94154.89140.34135.69130.74126.09
Month Ago155.64163.20170.52148.32140.76133.44125.88

EMA & SMA
info_icon

114.29

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 135.77

9 Day 131.18

10 Day 132.23

12 Day 135.36

14 Day 137.02

20 Day 140.47

26 Day 143.85

50 Day 154.35

100 Day 144.65

200 Day 130.33

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
HRTI PRIVATE LIMITEDbulkSell02 Dec, 2024₹169.116,09,695NSE
HRTI PRIVATE LIMITEDbulkBuy02 Dec, 2024₹168.975,60,819NSE
QE SECURITIES LLPbulkSell28 Nov, 2024₹158.958,09,581NSE
HRTI PRIVATE LIMITEDbulkSell28 Nov, 2024₹158.7312,84,003NSE
AAKRAYA RESEARCH LLPbulkSell28 Nov, 2024₹158.686,81,597NSE
QE SECURITIES LLPbulkBuy28 Nov, 2024₹157.257,63,464NSE
HRTI PRIVATE LIMITEDbulkBuy28 Nov, 2024₹158.8512,67,233NSE
AAKRAYA RESEARCH LLPbulkBuy28 Nov, 2024₹158.516,81,597NSE
GRAVITON RESEARCH CAPITAL LLPbulkSell08 Nov, 2023₹115.476,10,465NSE
GRAVITON RESEARCH CAPITAL LLPbulkBuy08 Nov, 2023₹115.406,10,465NSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
21 Feb, 2025Mr. Narsimha Shibroor KamathAcquisition₹127.5277,000NSE
21 Feb, 2025Mr. Narsimha Shibroor KamathAcquisition₹133.5923,000NSE
31 Oct, 2024Narsimha Shibroor KamathAcquisition₹122.462,00,000NSE
31 Oct, 2024Narsimha Shibroor KamathAcquisition₹115.841,80,000NSE
29 Nov, 2023Vibha Gagan Sharma RevisedAcquisition₹79.361,15,000NSE
19 Jun, 2023Vibha Gagan SharmaAcquisition₹1,15,000NSE
01 Mar, 2023Mr. Narsimha Shibroor KamathAcquisition₹79.083,00,000NSE
18 Feb, 2023Mr. Narsimha Shibroor KamathAcquisition₹77.971,00,000NSE
18 Feb, 2023Mr. Narsimha Shibroor KamathAcquisition₹76.932,00,000NSE
08 Jun, 2022Vibha Gagan SharmaAcquisition₹84.992,50,000NSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
03 May, 2024Rs.0.5000 per share(50%)Final Dividend18 Jul, 202401 Jan, 1970
11 May, 2023Rs.0.5000 per share(50%)Final Dividend12 Jul, 202301 Jan, 1970
02 May, 2022Rs.0.5000 per share(50%)Final Dividend20 Jun, 202201 Jan, 1970

Announcements

DateSourceDetail
30 Jan, 2025NSE IndiaPlease find attached Intergrated Filing (Financial) for the quarter and nine months ended December 31, 2024.
30 Jan, 2025BSE IndiaPlease find attached Intergrated Filing (Financial) for the quarter and nine months ended December 31, 2024
30 Jan, 2025NSE IndiaBliss GVS Pharma Limited has informed the Exchange about Copy of Newspaper Publication regarding the publication of the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine months ended December 31, 2024
29 Jan, 2025NSE IndiaBliss GVS Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
29 Jan, 2025BSE IndiaPlease find attached herewith a certificate received from MUFG Intime India Private Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities Exchange Board of India (Despositories and Participants) Regulations, 2018 for the quarter ended December 31, 2024.
28 Jan, 2025NSE IndiaBliss GVS Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on January 28, 2025.
28 Jan, 2025BSE IndiaPlease find attached the outcome of Board Meeting held on Tuesday, January 28, 2025.
28 Jan, 2025BSE IndiaPlease find the attached Outcome of Board Meeting held on Tuesday, January 28, 2025.
28 Jan, 2025NSE IndiaBliss GVS Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
21 Jan, 2025BSE IndiaBLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 ,inter alia, to consider and approve The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024; and\r\n\r\nThe proposal for issuance of Sweat Equity Shares pursuant to applicable provisions of the Companies Act, 2013, the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 and other applicable laws and regulations to Key Managerial Personnel and/or Senior Management Personnel and/or Employee(s) of the Company including determination of the issue price if any, subject to such regulatory and statutory approvals as may be required including approval of the shareholders of the Company. \r\n

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results & OthersTo consider other business matters.23 Jan, 202528 Jan, 2025
Quarterly Results--17 Oct, 202424 Oct, 2024
Quarterly Results--19 Jul, 202424 Jul, 2024
Audited Results & Final Dividend--29 Apr, 202402 May, 2024
Quarterly Results--17 Jan, 202423 Jan, 2024
Quarterly Results--27 Oct, 202301 Nov, 2023
Quarterly Results--27 Jul, 202301 Aug, 2023
Audited Results & Final Dividend--05 May, 202311 May, 2023
Quarterly Results--18 Jan, 202324 Jan, 2023
Quarterly Results--31 Oct, 202207 Nov, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Dec, 2023Dec, 2022Dec, 2021Dec, 2020
Promoter Group35.1%34.97%34.46%33.14%33.31%
Foreign Institutions +13.51%15.35%16.53%19.59%23.34%
Domestic Institutions +6.55%6.6%6.63%6.66%5.74%
Government0%0%0%0%0%
Public44.84%43.08%42.38%40.61%37.61%
Others0%0%0%0%0%

About Bliss GVS Pharma

Bliss GVS Pharma is a Public Limited Listed company incorporated on 11/12/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1984PLC034771 and registration number is 034771. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 605.46 Cr. and Equity Capital is Rs. 10.47 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Skypak Group

Founded

1984

Managing Director

Mr. Gagan Harsh Sharma

NSE Symbol

BLISSGVS

Bliss GVS Pharma Management

NameDesignation
Mr. S R VaidyaChairman & Ind.Director
Mr. Gagan Harsh SharmaManaging Director
Dr. Vibha Gagan SharmaWhole Time Director
Mrs. Shruti Vishal RaoWhole Time Director
Mr. Santosh L ParabIndependent Director
Ms. Shilpa BhatiaIndependent Woman Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)		₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)		₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)		₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)		₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)		₹1,093.000 - ₹1,420.200

FAQs on Bliss GVS Pharma

What is the share price of Bliss GVS Pharma?

The share price of Bliss GVS Pharma on 13 Mar, 2025 is ₹ 114.29.

What is 52W high and 52W low share price of Bliss GVS Pharma?

The highest and lowest 52W share prices of Bliss GVS Pharma are ₹ 184.950 and ₹ 92.250

What is the market cap of Bliss GVS Pharma?

The market capitalization of Bliss GVS Pharma as of 13 Mar, 2025 is ₹ 1,204.28 Crores

What is the P/E ratio of Bliss GVS Pharma?

The current P/E ratio of Bliss GVS Pharma as of 13 Mar, 2025 is 43.95

What is the PB ratio of Bliss GVS Pharma?

The PB ratio of Bliss GVS Pharma as of 13 Mar, 2025 is 1.19

Top Gainers

PASUSPG

Pasupati Spinning & Weaving Mills

₹41.02image

₹34.29 (0.20%)

OONE

ObjectOne Information Systems

₹8.84image

₹7.37 (0.20%)

JAINCO

Jainco Projects (India)

₹6.97image

₹5.81 (0.20%)

HITECHCORP

Hitech Corporation

₹194.70image

₹162.25 (0.20%)

Top Losers

MEHAI

Mehai Technology

₹13.75image

₹135.15 (-0.90%)

TRESCON

Trescon

₹9.60image

₹12.00 (-0.20%)

SAGL

Shalimar Agencies

₹9.80image

₹93.55 (-0.90%)

SHANGAR

Shangar Decor

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited